Products - Infants and neonates | Topic | NICE

Showing 6 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Baloxavir marboxil for treating influenza in babies under 1 year [ID6555]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Neonatal infection: antibiotics for prevention and treatment - risk factors for early onset neonatal infection
Status:
In development
Programme:
NICE guideline
Expected publication date:
13 May 2026
Rivogenlecleucel for treating haematological cancers in children and young people undergoing haploidentical haematopoietic stem cell transplant [ID1601]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Rivogenlecleucel for treating haematological non-malignant diseases in children and young people undergoing haploidentical haematopoietic stem cell transplant [ID1496]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tovorafenib for treating relapsed or refractory paediatric low-grade glioma with BRAF fusion or rearrangement or BRAF V600 mutation in people 6 months and over ID6557
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
VTS-270 for treating Niemann-Pick type C1 [ID1267]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
TBC